Summary
A dose-response study was carried out in male F344 rats with a specific urinary bladder carcinogen, N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN), which was administered as a solution in drinking water for up to 112 weeks. BBN was given in four different concentrations, 50, 10, 5, and 1 ppm, to groups of 30 rats. The highest dose induced urinary bladder cancer in all rats treated by week 91, decreasing yields being associated with lower dose levels: an incidence of 76.7% was observed with 10 ppm, followed by 20.0% with 5 ppm. The lowest dose (1 ppm) only induced two cases of papilloma (6.9%).
Similar content being viewed by others
References
Akagi G, Akagi A, Kimura M, Otsuka H (1973) Comparison of bladder tumors induced in rats and mice with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 64:331–336
Althoff J, Pour P, Grandjean C, Eagen M (1976) Transplacental effects of nitrosamines in Syrian hamsters. I. Dibutylnitrosamine and nitrosohexamethyleneamine. Z Krebsforsch 86:69–75
Bertram J, Craig AW (1972) Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer 8:587–594
Druckrey H, Schildbach A, Schmähl D, Preussmann R, Ivankovic S (1963) Quantitative Analyse der carcinogenen Wirkung von Diäthylnitrosamin. Arzneimittelforsch 13:841–846
Druckrey H, Preussmann R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW (1964) Selektive Erzeugung von Blasenkrebs an Ratten durch Dibutyl- und N-Butyl-N-Butano(4)-Nitrosamin. Z Krebsforsch 66:280–290
Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967) Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z Krebsforsch 69:103–201
Eisenbrand G, Habs D, Schmähl D, Preussmann R (1980) Carcinogenicity of N-nitroso-3-hydroxypyrrolidine and dose-response study with N-nitrosopiperidine in rats. In: N-Nitroso compounds: Analysis, formation and occurrence. International Agency for Research on Cancer, Lyons, pp657–663 (IARC scientific publication no. 31)
Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N (1982) Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Acta Pathol Jpn 32:243–250
Fukushima S, Imaida K, Sakata T, Okamura T, Shibata M, Ito N (1983) Promoting effects of sodium l-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res. 43:4454–4457
Goodman DG, Ward JM, Squire RA, Chu KC, Linhart MS (1979) Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol Appl Pharmacol 48:237–248
Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T, Takahashi M, Ito N (1976) Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Gann 67:175–189
Ito N, Hiasa Y, Tamai A, Okajima E, Kitamura H (1969) Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats. Gann 60:401–410
Ito N, Makiura S, Yokota Y, Kamamoto Y, Hias Y, Sugihara S (1971) Effect of unilateral ureter ligation on development of tumors in the urinary system on rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 62:359–365
Ito N, Matayoshi K, Matsumura K, Denda A, Kani T, Arai M, Makiura S (1974) Effects of various carcinogenic and non-carcinogenic substances on development of bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann 65:123–130
Ito N, Arai M, Sugihara S, Hirao K, Makiura S, Matayoshi K, Denda A (1975) Experimental urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann Monogr 17:367–381
Ito N, Shirai T, Miyata Y (1978) Production of urinary bladder tumors by administration of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) to pregnant, nursing and newborn rats. In: Severi L (ed) Tumours of early life in man and animals. Perugia Quadrennial International Conferences on Cancer, Monteluce, pp 495–503
Ito N, Tatematsu M, Nakanishi K, Hasegawa R, Takano T, Imaida K, Ogiso T (1980) Effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rat treated with N-nitrosodiethylamine and N-2-fluorenylacetamide. Gann 71:832–842
Kunze E (1979) Development of urinary bladder cancer in the rat. Curr Top Pathol 67:145–232
Lijinsky W, Reuber MD, Riggs CW (1981) Dose-response studies of carcinogenesis in rats by nitrosodiethylamine. Cancer Res 41:4997–5003
Maekawa A, Kurokawa Y, Takahashi M, Kokubo T, Ogiu T, Onodera H, Tanigawa H, Ohno Y, Furukawa F, Hayashi Y (1983) Spontaneous tumors in F-344/DuCrj rats. Gann 74:365–372
Nakanowatari J, Shibata M, Miyata Y, Hosoda K, Fukushima S (1983) Strain difference on BBN bladder carcinogenesis in rats (in Japanese) Proc Jpn Cancer Assoc 42:166
Okada M, Suzuki E, Aoki J, Iiyoshi M, Hashimoto Y (1975) Metabolism and carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine and related compounds, with special reference to induction of urinary bladder tumors. Gann Monogr 17:161–176
Okajima E, Hiramatsu T, Hirao K, Ijuin M, Hirao Y, Babaya K, Ikuma S, Ohara S, Shiomi T, Hijioka T, Ohishi H (1981) Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs. Cancer Res 41:1958–1966
Preussmann R (1976) Chemical carcinogens in the human environment. Problems and quantitative aspects. Oncology 33:51–57
Preussmann R (1980) The problem of thresholds in chemical carcinogenesis, Some views on theoretical and practical aspects. J Cancer Res Clin Oncol 97:1–14
Preussmann R, Schmähl D, Eisenbrand G (1977) Carcinogenicity of N-nitrosopyrrolidine; Dose-response study in rats. Z Krebsforsch 90:161–166
Schmähl D, Habs M (1980) Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism. Oncology 37:237–242
Spielhoff R, Bresch H, Hönig M, Mohr U (1974) Milk as transport agent for diethylnitrosamine in Syrian golden hamsters. J Natl Cancer Inst 53:281–282
Tatematsu M, Miyata Y, Mizutani M, Hananouchi M, Hirose M, Ito N (1977) Summation effect of N-butyl-N-(4-hydroxybutyl)-nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, N-2-fluorenylacetamide, and 3,3′-dichlorobenzidine on urinary bladder carcinogenesis in rats. Gann 68:193–202
Terracini B, Magee PN, Barnes JM (1967) Hepatic pathology in rats on low dietary levels of dimethylnitrosamine. Br J Cancer 21:559–565
Tsuda H, Miyata Y, Murasaki G, Kinoshita H, Fukushima S, Ito N (1977) Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, N-2-fluorenylacetamide, and 3,3′-dichlorobenzidine. Gann 68:183–192
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Hermann Druckrey on the occasion of his 80th birthday
Supported in part by Grants-in-Aid for Cancer Research from the Ministry of Education, Science and Culture and the Ministry of Health and Welfare of Japan, the Japan Tobacco and Salt Public Corporation, and the Experimental Pathological Research Association
Rights and permissions
About this article
Cite this article
Ito, N., Shirai, T., Fukushima, S. et al. Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. J Cancer Res Clin Oncol 108, 169–173 (1984). https://doi.org/10.1007/BF00390992
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00390992